Net Health Systems

Net Health Systems

Net Health Systems operates as a private equity-backed holding company focused on specialized healthcare software. The firm was built through acquisitions under a strategy to own point-solution EHRs in markets typically overlooked by enterprise vendors. Financial backing has historically come from private equity sponsors, including a period of ownership by The Carlyle Group before its sale to Level Equity. The firm is not a traditional family office but a consolidator deploying sponsor capital into a defined corner of the healthcare IT landscape. The firm's core assets are purpose-built software platforms for wound care, outpatient physical therapy, and employee health. Its flagship EHRs serve hospital-based wound centers and skilled nursing facilities, managing compliance and clinical documentation for hyperbaric medicine and chronic wound tracking. The therapy management division addresses clinic chains and private practice rehabilitation providers. In the employee health vertical, Net Health provides occupational medicine solutions for corporate clinics, government agencies, and hospitals tracking workforce injury and exposure. These are businesses with persistent reimbursement codependency and high-tail compliance risk — a defensive posture compared to telemedicine darlings. Major investments have centered on deepening analytic modules, including AI-assisted wound measurement tools and predictive analytics for hospital readmission risk within its existing install base, though specific deal-level returns remain undisclosed. With roots as a Carnegie Mellon start-up and later scaling via institutional capital, Net Health has operated as a portfolio company rather than an independent fund. The firm was acquired by The Carlyle Group in 2017 before Level Equity and its management team closed a recapitalization in 2020. Its Pittsburgh headquarters anchors a workforce concentrated in software development, client services, and regulatory expertise. In November 2023, Net Health announced a reorganization integrating its wound care and therapy divisions under a unified commercial structure following the resignation of its CEO Josh Pickus and the elevation of Ron Books, an operating partner at sponsor Level Equity, signaling a tighter investor-operator grip. Net Health's structural differentiator is not a single fund but its position as a consolidator within the sponsor ecosystem — a platform built through sequential acquisitions of micro-vertical EHRs. This creates a bundled recurring-revenue business model where growth depends on cross-selling analytics into a captive base of specialty clinics rather than winning new logo enterprise contracts. The Carlyle-to-Level-Equity transition illustrates a classic mid-market private equity path: a carve-out from a mega-fund scaling platform for a more focused second act.